Oncology Today with Dr Neil Love

348 Epizód

1. Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

   Közzétéve: 2024. 05. 20.
2. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

   Közzétéve: 2024. 05. 13.
3. Virtual Case Library: Metastatic Triple-Negative Breast Cancer

   Közzétéve: 2024. 05. 08.
4. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

   Közzétéve: 2024. 05. 06.
5. Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

   Közzétéve: 2024. 05. 03.
6. Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

   Közzétéve: 2024. 05. 01.
7. Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

   Közzétéve: 2024. 04. 26.
8. Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

   Közzétéve: 2024. 04. 24.
9. Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

   Közzétéve: 2024. 04. 23.
10. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

    Közzétéve: 2024. 04. 15.
11. Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Közzétéve: 2024. 04. 12.
12. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

    Közzétéve: 2024. 04. 05.
13. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

    Közzétéve: 2024. 04. 05.
14. The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Közzétéve: 2024. 04. 03.
15. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

    Közzétéve: 2024. 03. 27.
16. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Közzétéve: 2024. 03. 26.
17. Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

    Közzétéve: 2024. 03. 25.
18. Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

    Közzétéve: 2024. 03. 21.
19. Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Közzétéve: 2024. 03. 19.
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

    Közzétéve: 2024. 03. 15.